Endoscopic ultrasound-guided transrectal biopsies of pelvic tumors

Standard

Endoscopic ultrasound-guided transrectal biopsies of pelvic tumors. / Sailer, Marco; Bussen, Dieter; Fein, Martin; Freys, Stephan; Debus, Sebastian E; Thiede, Arnulf; Fuchs, Karl-Hermann.

In: J GASTROINTEST SURG, Vol. 6, No. 3, 23.05.2002, p. 342-346.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Sailer, M, Bussen, D, Fein, M, Freys, S, Debus, SE, Thiede, A & Fuchs, K-H 2002, 'Endoscopic ultrasound-guided transrectal biopsies of pelvic tumors', J GASTROINTEST SURG, vol. 6, no. 3, pp. 342-346. https://doi.org/10.1016/s1091-255x(01)00012-9

APA

Sailer, M., Bussen, D., Fein, M., Freys, S., Debus, S. E., Thiede, A., & Fuchs, K-H. (2002). Endoscopic ultrasound-guided transrectal biopsies of pelvic tumors. J GASTROINTEST SURG, 6(3), 342-346. https://doi.org/10.1016/s1091-255x(01)00012-9

Vancouver

Bibtex

@article{97715bcb3d0443adba0131907263ed46,
title = "Endoscopic ultrasound-guided transrectal biopsies of pelvic tumors",
abstract = "The aim of this study was to evaluate the feasibility, safety, and diagnostic accuracy of endorectal ultrasound-guided biopsies in patients with extrarectal lesions. Data from all patients with suspicious pelvic pathology who underwent endorectal ultrasound-guided biopsies were collected prospectively. To evaluate the accuracy of the diagnosis, all patients with benign histology but primary suspicion of a malignant lesion were followed up for at least 12 months. A total of 48 patients whose median age was 66 years were evaluated. Apart from one postbiopsy hemorrhage, which was managed conservatively, no other complications were encountered. Sufficient tissue was removed to allow histologic examination in all cases. A large variety of diagnoses including primary and secondary malignancies (n = 25) as well as benign pathologies (n = 23) could be established. There were no false positive but three false negative histologies in patients with proven local recurrence of a malignant tumor during the follow-up period. This results in a sensitivity of 88%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 89%. It is concluded that endoscopic ultrasound-guided transrectal biopsy is a safe method with a high diagnostic accuracy in the assessment of pelvic tumors.",
keywords = "Adolescent, Adult, Aged, Aged, 80 and over, Biopsy, Needle/methods, Colorectal Neoplasms/diagnostic imaging, Endosonography, Female, Humans, Male, Middle Aged, Sensitivity and Specificity",
author = "Marco Sailer and Dieter Bussen and Martin Fein and Stephan Freys and Debus, {Sebastian E} and Arnulf Thiede and Karl-Hermann Fuchs",
year = "2002",
month = may,
day = "23",
doi = "10.1016/s1091-255x(01)00012-9",
language = "English",
volume = "6",
pages = "342--346",
journal = "J GASTROINTEST SURG",
issn = "1091-255X",
publisher = "Springer New York",
number = "3",

}

RIS

TY - JOUR

T1 - Endoscopic ultrasound-guided transrectal biopsies of pelvic tumors

AU - Sailer, Marco

AU - Bussen, Dieter

AU - Fein, Martin

AU - Freys, Stephan

AU - Debus, Sebastian E

AU - Thiede, Arnulf

AU - Fuchs, Karl-Hermann

PY - 2002/5/23

Y1 - 2002/5/23

N2 - The aim of this study was to evaluate the feasibility, safety, and diagnostic accuracy of endorectal ultrasound-guided biopsies in patients with extrarectal lesions. Data from all patients with suspicious pelvic pathology who underwent endorectal ultrasound-guided biopsies were collected prospectively. To evaluate the accuracy of the diagnosis, all patients with benign histology but primary suspicion of a malignant lesion were followed up for at least 12 months. A total of 48 patients whose median age was 66 years were evaluated. Apart from one postbiopsy hemorrhage, which was managed conservatively, no other complications were encountered. Sufficient tissue was removed to allow histologic examination in all cases. A large variety of diagnoses including primary and secondary malignancies (n = 25) as well as benign pathologies (n = 23) could be established. There were no false positive but three false negative histologies in patients with proven local recurrence of a malignant tumor during the follow-up period. This results in a sensitivity of 88%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 89%. It is concluded that endoscopic ultrasound-guided transrectal biopsy is a safe method with a high diagnostic accuracy in the assessment of pelvic tumors.

AB - The aim of this study was to evaluate the feasibility, safety, and diagnostic accuracy of endorectal ultrasound-guided biopsies in patients with extrarectal lesions. Data from all patients with suspicious pelvic pathology who underwent endorectal ultrasound-guided biopsies were collected prospectively. To evaluate the accuracy of the diagnosis, all patients with benign histology but primary suspicion of a malignant lesion were followed up for at least 12 months. A total of 48 patients whose median age was 66 years were evaluated. Apart from one postbiopsy hemorrhage, which was managed conservatively, no other complications were encountered. Sufficient tissue was removed to allow histologic examination in all cases. A large variety of diagnoses including primary and secondary malignancies (n = 25) as well as benign pathologies (n = 23) could be established. There were no false positive but three false negative histologies in patients with proven local recurrence of a malignant tumor during the follow-up period. This results in a sensitivity of 88%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 89%. It is concluded that endoscopic ultrasound-guided transrectal biopsy is a safe method with a high diagnostic accuracy in the assessment of pelvic tumors.

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Biopsy, Needle/methods

KW - Colorectal Neoplasms/diagnostic imaging

KW - Endosonography

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Sensitivity and Specificity

U2 - 10.1016/s1091-255x(01)00012-9

DO - 10.1016/s1091-255x(01)00012-9

M3 - SCORING: Journal article

C2 - 12022985

VL - 6

SP - 342

EP - 346

JO - J GASTROINTEST SURG

JF - J GASTROINTEST SURG

SN - 1091-255X

IS - 3

ER -